170 related articles for article (PubMed ID: 30198200)
1. Pectoralis major radiation recall.
Hack E; Thachil T; Karanth N
J Med Radiat Sci; 2019 Mar; 66(1):62-65. PubMed ID: 30198200
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
3. [Myositis as a 'radiation-recall phenomenon' following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma].
Pinson PJ; Griep C; Sanders WH; Lelie B
Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1891-4. PubMed ID: 16970014
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of radiation myositis probably induced by recall phenomenon].
Miura G; Matsumoto T; Tanaka N; Emoto T; Kawamura T; Matsunaga N
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):420-2. PubMed ID: 14587415
[TBL] [Abstract][Full Text] [Related]
5. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
[TBL] [Abstract][Full Text] [Related]
6. [Combined gemcitabine and radiotherapy].
Mornex F
Bull Cancer; 2002 Aug; 89 Spec No():S127-33. PubMed ID: 12449044
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art.
Mornex F; Girard N
Ann Oncol; 2006 Dec; 17(12):1743-7. PubMed ID: 16766586
[TBL] [Abstract][Full Text] [Related]
9. A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer.
van Putten JW; Price A; van der Leest AH; Gregor A; Little FA; Groen HJ
Clin Cancer Res; 2003 Jul; 9(7):2472-7. PubMed ID: 12855620
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-induced radiation recall myositis.
Delavan JA; Chino JP; Vinson EN
Skeletal Radiol; 2015 Mar; 44(3):451-5. PubMed ID: 25193536
[TBL] [Abstract][Full Text] [Related]
11. An unusual case of gemcitabine-induced radiation recall.
Squire S; Chan M; Feller E; Mega A; Gold R
Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
[No Abstract] [Full Text] [Related]
12. Radiation recall reaction following gemcitabine.
Fogarty G; Ball D; Rischin D
Lung Cancer; 2001; 33(2-3):299-302. PubMed ID: 11551425
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
Zinner RG; Komaki R; Cox JD; Glisson BS; Pisters KM; Herbst RS; Kies M; Liao Z; Hong WK; Fossella FV
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):119-27. PubMed ID: 18556142
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
[TBL] [Abstract][Full Text] [Related]
16. Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies.
Harrington C; James M; Wynne C
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):561-3. PubMed ID: 20570499
[TBL] [Abstract][Full Text] [Related]
17. A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings.
Senzer N
Semin Oncol; 2002 Dec; 29(6 Suppl 19):38-41. PubMed ID: 12577242
[TBL] [Abstract][Full Text] [Related]
18. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
[TBL] [Abstract][Full Text] [Related]
19. Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.
Cesario A; Margaritora S; Trodella L; Valente S; Corbo GM; Macis G; Galetta D; d'Angelillo RM; Porziella V; Ramella S; Mangiacotti MG; Granone P
Lung Cancer; 2002 Aug; 37(2):207-12. PubMed ID: 12140144
[TBL] [Abstract][Full Text] [Related]
20. Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.
Galetta D; Cesario A; Margaritora S; Porziella V; Piraino A; D'Angelillo RM; Gambacorta MA; Ramella S; Trodella L; Valente S; Corbo GM; Macis G; Mulè A; Cardaci V; Sterzi S; Granone P; Russo P
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):314-21. PubMed ID: 16434259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]